Core A: Administrative
Core A: Administrative
批准号:
10668335
负责人:
KORNELIA POLYAK
金额:
$20.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
未结题
起止时间:
2013-09-17 至 2025-05-31
关键词:
AccountingAdvocacyAdvocateAgreementAwardBreastCancer CenterClinicalClinical DataClinical ResearchClinical TrialsCollaborationsCommunicationConduct Clinical TrialsDana-Farber Cancer InstituteDevelopmentEducational ActivitiesEnsureEvaluationFundingGrantInfrastructureLeadershipMonitorOffice ManagementOffice of Administrative ManagementPatient advocacyPatient-Focused OutcomesPatientsPreparationReportingReproduction sporesResearchResearch ActivityResearch PersonnelResearch Project GrantsResource SharingResourcesRoleSiteTranslational ResearchUpdateWorkcareerdisorder riskimproved outcomemalignant breast neoplasmmeetingspatient engagementprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The role of the Administration, Advocacy, Planning and Communication Core (Administrative Core - Core A) is
to coordinate and integrate the multiple components of the Dana-Farber/Harvard Cancer Center (DF/HCC)
Breast Cancer SPORE and to provide scientific, administrative and fiscal oversight of the SPORE Projects,
Cores, the Developmental Research Program (DRP) and the Career Enhancement Program (CEP).
Administrative Management: Core A will facilitate the coordination of the Breast SPORE within the DF/HCC to
meet our scientific aims. Core A will provide the infrastructure for fiscal and administrative oversight for the Breast
Cancer SPORE, including financial accounting and reporting, coordination of research agreements and pre-and
post-award monitoring and reporting in close collaboration with the grants management office at Dana-Farber
Cancer Institute.
Clinical Research Management: Core A will support all investigators in the Breast SPORE conducting clinical
trials and facilitate the interaction and collaborations in the preparation, review and activation of clinical studies
within the DF/HCC Breast Program and external sites.
Integration of SPORE within DF/HCC: Core A will promote coordination and communication between SPORE
investigators, the DF/HCC and its leadership, the DF/HCC Breast Program and its established committees that
support clinical trial development, review, activation and management, as well as access and use of
biospecimens and associated clinical data. Core A will coordinate the Shared Resources Leadership Committee
comprised of the core directors, project leaders, patient advocates and DF/HCC investigators, as well as monthly
Research-in-Progress meetings for frequent updates on progress in the Breast SPORE.
Patient Advocacy: The Core will integrate the work of our large and highly interactive Patient Advocacy
Committee into the planning and evaluation of the Breast SPORE, with guidance from Elizabeth Frank, EdM, as
co-investigator of Core A. The Core will seek to fully engage the patient advocates in the four SPORE Projects,
the DRP, the CEP and the Cores to ensure that the patient perspective is taken into account in the
clinical/translational research.
Planning and Evaluation: Core A will provide rigorous scientific leadership and oversight for the SPORE
Projects, the Cores, the DRP and the CEP. Core A will organize meetings of the Breast SPORE External
Advisory Board (EAB) and Internal Advisory Board (IAB) for evaluation on findings and progress across the
Breast SPORE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic mechanisms of therapeutic resistance
-
批准号:10627962
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
-
批准号:10627981
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
-
批准号:10261469
-
项目类别:
-
资助金额:$11.58万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Epigenetic mechanisms of therapeutic resistance
-
批准号:10434103
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
New therapeutic vulnerabilities in breast cancer
-
批准号:10434102
-
项目类别:
-
资助金额:$171.86万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
New therapeutic vulnerabilities in breast cancer
-
批准号:10627961
-
项目类别:
-
资助金额:$171.86万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Epigenetic mechanisms of therapeutic resistance
-
批准号:10023397
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
-
批准号:10023400
-
项目类别:
-
资助金额:$12.49万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
New therapeutic vulnerabilities in breast cancer
-
批准号:10261465
-
项目类别:
-
资助金额:$175.37万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Epigenetic mechanisms of therapeutic resistance
-
批准号:10261466
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
New therapeutic vulnerabilities in breast cancer
-
批准号:10023396
-
项目类别:
-
资助金额:$177.3万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
-
批准号:10434106
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Targeting intratumor heterogeneity in breast cancer
-
批准号:9328033
-
项目类别:
-
资助金额:$54.67万
-
财政年份:2015
-
负责人:KORNELIA POLYAK
-
依托单位:
Targeting intratumor heterogeneity in breast cancer
-
批准号:10208794
-
项目类别:
-
资助金额:$115.71万
-
财政年份:2015
-
负责人:KORNELIA POLYAK
-
依托单位:
Project 3: Single Cell Measures of Intratumor Diversity for Optimal Breast Cancer Therapy
-
批准号:8866714
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2015
-
负责人:KORNELIA POLYAK
-
依托单位:
Targeting intratumor heterogeneity in breast cancer
-
批准号:10705709
-
项目类别:
-
资助金额:$101.55万
-
财政年份:2015
-
负责人:KORNELIA POLYAK
-
依托单位:
The Role of P27 in Breast Epithelial Progenitors and Breast Cancer Risk
-
批准号:8633710
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2014
-
负责人:KORNELIA POLYAK
-
依托单位:
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
-
批准号:10668347
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2013
-
负责人:KORNELIA POLYAK
-
依托单位:
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
-
批准号:10215416
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2013
-
负责人:KORNELIA POLYAK
-
依托单位:
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
-
批准号:10455693
-
项目类别:
-
资助金额:$29.06万
-
财政年份:2013
-
负责人:KORNELIA POLYAK
-
依托单位:
海外基金